Trinity Biotech PLC (TRIB)
1.802
+0.12
(+7.27%)
USD |
NASDAQ |
May 03, 16:00
1.76
-0.04
(-2.34%)
After-Hours: 20:00
Trinity Biotech Free Cash Flow (Quarterly): -0.649M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.649M |
September 30, 2023 | -5.284M |
June 30, 2023 | -4.981M |
March 31, 2023 | -3.347M |
December 31, 2022 | 0.694M |
September 30, 2022 | -0.648M |
June 30, 2022 | -3.736M |
March 31, 2022 | -3.208M |
December 31, 2021 | 1.855M |
September 30, 2021 | -0.262M |
June 30, 2021 | -0.232M |
March 31, 2021 | 3.186M |
December 31, 2020 | 12.57M |
September 30, 2020 | 4.34M |
June 30, 2020 | 0.80M |
March 31, 2020 | -4.152M |
December 31, 2019 | -3.247M |
September 30, 2019 | -1.415M |
June 30, 2019 | 1.868M |
March 31, 2019 | -3.642M |
December 31, 2018 | -3.166M |
September 30, 2018 | -9.313M |
June 30, 2018 | 5.595M |
March 31, 2018 | -3.278M |
December 31, 2017 | -3.00M |
Date | Value |
---|---|
September 30, 2017 | 0.344M |
June 30, 2017 | 0.248M |
March 31, 2017 | -4.522M |
December 31, 2016 | -2.771M |
September 30, 2016 | -0.169M |
June 30, 2016 | -4.91M |
March 31, 2016 | -3.797M |
December 31, 2015 | -4.254M |
September 30, 2015 | -0.713M |
June 30, 2015 | -6.218M |
March 31, 2015 | -3.357M |
December 31, 2014 | -3.359M |
September 30, 2014 | -1.174M |
June 30, 2014 | -2.905M |
March 31, 2014 | -4.259M |
December 31, 2013 | -8.176M |
September 30, 2013 | -1.233M |
June 30, 2013 | -2.558M |
March 31, 2013 | -1.852M |
December 31, 2012 | -0.732M |
September 30, 2012 | 1.919M |
June 30, 2012 | 2.096M |
March 31, 2012 | 1.382M |
December 31, 2011 | 1.29M |
September 30, 2011 | 3.042M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.284M
Minimum
Sep 2023
12.57M
Maximum
Dec 2020
-0.3078M
Average
-0.648M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
Avadel Pharmaceuticals PLC | -28.03M |
Amarin Corp PLC | -1.154M |
DBV Technologies SA | -14.04M |
Adaptimmune Therapeutics PLC | -15.50M |
Akari Therapeutics PLC | -- |